Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,534Revenue $M201Net Margin (%)9.0Altman Z-Score-1.2
Enterprise Value $M1,362EPS $-0.4Operating Margin %21.7Piotroski F-Score6
P/E(ttm)69.7Beneish M-Score-1.5Pre-tax Margin (%)8.8Higher ROA y-yY
Price/Book20.010-y EBITDA Growth Rate %--Quick Ratio4.4Cash flow > EarningsN
Price/Sales5.35-y EBITDA Growth Rate %-28.7Current Ratio4.6Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)5.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)113Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M131ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with NKTR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NKTRFirst Eagle Investment 2011-12-31 Sold Out -0.003%$4.22 - $5.62
($4.9)
$ 11.66138%Sold Out0
NKTRFirst Eagle Investment 2011-09-30 Buy $4.98 - $7.65
($5.97)
$ 11.6695%New holding125,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NKTR is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


NKTR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KUEBLER CHRISTOPHER ADirector 2015-01-13Sell15,000$16-27.13 view
CHESS ROBERTDirector 2014-12-29Sell29,500$15.34-23.99 view
Thomsen Jillian B.SVP & Chief Accounting Officer 2014-12-22Sell5,000$15.56-25.06 view
Labrucherie Gil MSVP & General Counsel 2014-12-01Sell120,000$17.02-31.49 view
ROBIN HOWARD WPresident & CEO 2014-12-01Sell350,000$17.01-31.45 view
ROBIN HOWARD WPresident & CEO 2014-11-25Sell600,000$15.25-23.54 view
Labrucherie Gil MSVP & General Counsel 2014-11-24Sell10,500$15.04-22.47 view
Lingnau LutzDirector 2014-11-24Sell15,000$15.02-22.37 view
Labrucherie Gil MSVP & General Counsel 2014-11-03Sell9,900$13.78-15.38 view
WHITFIELD ROY ADirector 2013-08-05Sell12,500$12.41-6.04 view

Press Releases about NKTR :

    Quarterly/Annual Reports about NKTR:

    News about NKTR:

    Articles On GuruFocus.com
    Weekly Guru Bargains Highlights: AKAM, NKTR, LOGI, FFIV, LCC Apr 16 2011 
    Weekly Guru Bargains Highlights: AMSC, LOGI, NKTR, DAL, AIG Apr 09 2011 
    Four Guru Stocks near New Lows: FBN, HOME, NKTR, PETS Feb 07 2011 
    MannKind: Deja Vu for the FDA and Afrezza Dec 29 2010 
    Nektar Therapeutics Reports Operating Results (10-Q) Nov 04 2010 
    Nektar Therapeutics Reports Operating Results (10-Q) Jul 29 2010 
    Nektar Therapeutics Reports Operating Results (10-Q) May 06 2010 
    cooldecency99 note on NKTR May 01 2010 
    Small-Cap Biotech Stocks: Why This Sector Is Set for a Huge Year Jan 06 2010 
    Nektar Therapeutics Reports Operating Results (10-Q) Nov 05 2009 

    More From Other Websites
    Biotech Fans Could Have a Hangover May 14 2015
    Nektar Swings to Q1 Earnings, Updates 2015 Guidance - Analyst Blog May 04 2015
    10-Q for Nektar Therapeutics May 03 2015
    NEKTAR THERAPEUTICS Files SEC form 10-Q, Quarterly Report May 01 2015
    Nektar tops Street 1Q forecasts Apr 30 2015
    Nektar tops Street 1Q forecasts Apr 30 2015
    Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 Apr 30 2015
    NEKTAR THERAPEUTICS Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Apr 30 2015
    Nektar Therapeutics Earnings Call scheduled for 5:00 pm ET today Apr 30 2015
    Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 Apr 30 2015
    Q1 2015 Nektar Therapeutics Earnings Release - After Market Close Apr 30 2015
    Baxter (BAX) Beats Q1 Earnings Estimates, Sales Down Y/Y - Analyst Blog Apr 24 2015
    Nektar to Announce Financial Results for the First Quarter 2015 on Thursday, April 30, 2015, After... Apr 23 2015
    Nektar to Announce Financial Results for the First Quarter 2015 on Thursday, April 30, 2015, After... Apr 23 2015
    Will Baxter's (BAX) Earnings Disappoint Estimates in Q1? - Analyst Blog Apr 21 2015
    Baxter (BAX) Presents Positive Phase 3 Data for BAX 111 - Analyst Blog Apr 20 2015
    5 Big Biotechs Not Keeping Up at All With Hot Biotech Sector in 2015 Apr 18 2015
    Baxter Files New Drug Application for BAX 855 in Japan - Analyst Blog Apr 17 2015
    Huge Biotech Index Rebalance Means Massive Buy Orders for These 4 Stocks Apr 17 2015
    Baxter Submits Application To Japan's MHLW For Approval Of BAX 855, Extended Half-Life Recombinant... Apr 16 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK